U.S. Physical Therapy, Inc. (NYSE:USPH) Receives $97.50 Consensus Target Price from Analysts

U.S. Physical Therapy, Inc. (NYSE:USPH) has been given an average recommendation of “Moderate Buy” by the seven ratings firms that are presently covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation, four have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $97.50.

Several analysts have recently issued reports on USPH shares. Citigroup reissued an “outperform” rating on shares of U.S. Physical Therapy in a research note on Friday, May 8th. Zacks Research raised shares of U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a research report on Wednesday, May 27th. Citizens Jmp decreased their price target on shares of U.S. Physical Therapy from $113.00 to $98.00 and set a “market outperform” rating for the company in a research report on Friday, May 8th. Jefferies Financial Group raised shares of U.S. Physical Therapy to a “strong-buy” rating in a research report on Thursday, March 12th. Finally, Barrington Research decreased their price target on shares of U.S. Physical Therapy from $103.00 to $90.00 and set an “outperform” rating for the company in a research report on Wednesday, May 13th.

U.S. Physical Therapy Stock Up 0.2%

Shares of NYSE USPH opened at $64.39 on Wednesday. U.S. Physical Therapy has a 52-week low of $58.19 and a 52-week high of $93.50. The firm has a fifty day moving average of $70.53 and a 200-day moving average of $76.84. The stock has a market capitalization of $979.99 million, a PE ratio of 128.78, a P/E/G ratio of 1.78 and a beta of 1.16. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.41.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $0.46 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.55 by ($0.09). U.S. Physical Therapy had a net margin of 4.36% and a return on equity of 8.81%. The company had revenue of $198.29 million for the quarter, compared to analysts’ expectations of $200.94 million. During the same period in the prior year, the firm earned $0.48 earnings per share. The firm’s quarterly revenue was up 7.9% on a year-over-year basis. On average, analysts anticipate that U.S. Physical Therapy will post 2.99 EPS for the current year.

U.S. Physical Therapy Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 12th. Investors of record on Friday, May 22nd will be given a dividend of $0.46 per share. This represents a $1.84 dividend on an annualized basis and a yield of 2.9%. The ex-dividend date of this dividend is Friday, May 22nd. U.S. Physical Therapy’s dividend payout ratio is 368.00%.

Insiders Place Their Bets

In related news, EVP Richard Binstein sold 3,000 shares of the company’s stock in a transaction on Friday, March 6th. The shares were sold at an average price of $81.64, for a total transaction of $244,920.00. Following the completion of the sale, the executive vice president directly owned 24,867 shares of the company’s stock, valued at approximately $2,030,141.88. This represents a 10.77% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Graham D. Reeve sold 662 shares of the company’s stock in a transaction on Wednesday, March 11th. The stock was sold at an average price of $78.86, for a total transaction of $52,205.32. Following the sale, the chief operating officer directly owned 30,078 shares of the company’s stock, valued at approximately $2,371,951.08. This trade represents a 2.15% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 2.40% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On U.S. Physical Therapy

A number of institutional investors and hedge funds have recently added to or reduced their stakes in USPH. Royal Bank of Canada boosted its position in U.S. Physical Therapy by 3.4% in the 1st quarter. Royal Bank of Canada now owns 79,238 shares of the company’s stock valued at $5,733,000 after buying an additional 2,594 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in U.S. Physical Therapy by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 8,897 shares of the company’s stock valued at $644,000 after buying an additional 391 shares during the last quarter. Jane Street Group LLC boosted its position in U.S. Physical Therapy by 249.3% in the 1st quarter. Jane Street Group LLC now owns 49,309 shares of the company’s stock valued at $3,568,000 after buying an additional 35,191 shares during the last quarter. Hsbc Holdings PLC purchased a new position in U.S. Physical Therapy in the 2nd quarter valued at about $410,000. Finally, First Trust Advisors LP boosted its position in U.S. Physical Therapy by 3.7% in the 2nd quarter. First Trust Advisors LP now owns 10,725 shares of the company’s stock valued at $839,000 after buying an additional 385 shares during the last quarter.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.